跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VFEND voriconazole 40mg/mL powder for suspension bottle - TGA Drug Approval Details
Approvals
/
TGA
/
VFEND voriconazole 40mg/mL powder for suspension bottle
Approved
STANDARD
VFEND voriconazole 40mg/mL powder for suspension bottle
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
afe5d1aa4cf516c3
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
afe5d1aa4cf516c3
Product Name
VFEND voriconazole 40mg/mL powder for suspension bottle
Artg Id
99016
Artg Name
VFEND voriconazole 40mg/mL powder for suspension bottle
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
2004-01-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/9cca1dccae4f0b14b66c292b0bbbe8d9.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/725849eb9d4c6a6179f1d6124c2f2fee.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
afe5d1aa4cf516c3
Type
Standard
Back to TGA Approvals